A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis. The anticancer drugs ...
... the most common cancers worldwide. By knowing the mechanism of action of Alisol B acetate, it may provide a new therapeutic option, as a potential anticancer agent, in the treatment of gastric cancer.
... trioxide to treat other types of cancer are under way, but clinical trials are revealing that the extreme toxicity of this material is likely to limit its utility as a broad-spectrum anticancer agent.
... Both compounds are analogues of cisplatin, a potent anticancer agent, but the newly investigated compound, known ... co-lead author of the paper.
cDPCP's anticancer activity was first observed in mice 20 ...
... , Luesch said, and one drug recently approved in Europe is the first-ever marine-derived anticancer agent.
"Marine study is in its infancy," said William Fenical, Ph.D., a distinguished professor of ...
Platinum-based anticancer agents have a long history as proven therapeutic agents, but their toxicity and short lifetime in the body and the ability of tumors to develop resistance to these drugs ...
... senescence helps protect against the formation of tumors and aids in the response to certain anticancer agents.
Interestingly, the researchers said, senescent cells had also been observed in some ...
... bugs — the ones that can be grown easily in a lab — that have brought us antibiotics, anticancer agents and other useful drugs. The odds favor the other 99 percent for clinical promise, too, but ...
... ,000 species of bacteria, but it's only one percent of these microbial bugs -- the ones that can be grown easily in a lab -- that have brought us antibiotics, anticancer agents and other useful drugs.
A programmable gene cluster could offer a route to new antitumor drugs
... /5,000 the diameter of a human hair encapsulating an experimental anticancer agent, kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures. ...
... make up the machinery that cells use to separate the chromosomes. SFN, like the more powerful anticancer agents, interferes with microtubule functioning during mitosis in a similar manner to the more ...
... -- 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent -- can kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures.
... compound in green tea called the EGCG polyphenol (epigallocatechin gallate) has been shown to be a potent anticancer agent, with effects demonstrated against leukemia, as well as lung, prostate, ...
... overexpression of the transcription factor SOX9 restores the sensitivity of mouse and human melanomas to the anticancer agent retinoic acid, thereby stopping tumor growth. The authors suggest that a ...
